10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Distal Gastrectomy with Billroth II Reconstruction is Associated with Oralization of Gut Microbiome and Intestinal Inflammation: A Proof-of-Concept Study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Subtotal gastrectomy with Billroth II reconstruction (SGB2) results in increased gastric pH and diminished gastric barrier. Increased gastric pH following PPI therapy has an impact on the gut microbiome, intestinal inflammation, and possibly patient health. If similar changes are present after SGB2, these can be relevant for patient health and long-term outcomes after surgery. The aim of the study is to investigate whether SGB2 is associated with specific changes in gut microbiome composition and intestinal inflammation.

          Patients and Methods

          This cross-sectional proof-of-concept study includes patients after SGB2 ( n = 14) for early gastric cancer and their nongastrectomized in-house relatives as controls ( n = 8). Fecal microbiome composition, intestinal inflammation (fecal calprotectin), gut permeability (DAO, LBP, sCD14), systemic inflammation (CRP) markers, and gastrointestinal symptoms are investigated. This study is registered at ClinicalTrials.gov (NCT03418428).

          Results

          Microbiome oralization following SGB2 was defined by an increase in EscherichiaShigella, Enterococcus, Streptococcus, and other typical oral cavity bacteria ( Veillonella, Oribacterium, and Mogibacterium) abundance. The fecal calprotectin was increased in the SGB2 group [100.9 (52.1; 292) vs. 25.8 (17; 66.5); p = 0.014], and calprotectin levels positively correlated with the abundance of Streptococcus ( r s = 0.639; p adj = 0.023). Gastrointestinal symptoms in SGB2 patients were associated with distinct taxonomic changes of the gut microbiome.

          Conclusions

          SGB2 is associated with oralization of the gut microbiome; intestinal inflammation and microbiome changes were associated with gastrointestinal symptoms. These novel findings may open gut microbiome as a new target for therapy to improve quality of life and general patient health in long-term survivors after SGB2.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: found
          • Article: not found

          DADA2: High resolution sample inference from Illumina amplicon data

          We present DADA2, a software package that models and corrects Illumina-sequenced amplicon errors. DADA2 infers sample sequences exactly, without coarse-graining into OTUs, and resolves differences of as little as one nucleotide. In several mock communities DADA2 identified more real variants and output fewer spurious sequences than other methods. We applied DADA2 to vaginal samples from a cohort of pregnant women, revealing a diversity of previously undetected Lactobacillus crispatus variants.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            QIIME allows analysis of high-throughput community sequencing data.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Environment dominates over host genetics in shaping human gut microbiota

              Human gut microbiome composition is shaped by multiple factors but the relative contribution of host genetics remains elusive. Here we examine genotype and microbiome data from 1,046 healthy individuals with several distinct ancestral origins who share a relatively common environment, and demonstrate that the gut microbiome is not significantly associated with genetic ancestry, and that host genetics have a minor role in determining microbiome composition. We show that, by contrast, there are significant similarities in the compositions of the microbiomes of genetically unrelated individuals who share a household, and that over 20% of the inter-person microbiome variability is associated with factors related to diet, drugs and anthropometric measurements. We further demonstrate that microbiome data significantly improve the prediction accuracy for many human traits, such as glucose and obesity measures, compared to models that use only host genetic and environmental data. These results suggest that microbiome alterations aimed at improving clinical outcomes may be carried out across diverse genetic backgrounds.
                Bookmark

                Author and article information

                Contributors
                abpelikanas@gmail.com
                Journal
                Ann Surg Oncol
                Ann Surg Oncol
                Annals of Surgical Oncology
                Springer International Publishing (Cham )
                1068-9265
                1534-4681
                5 June 2020
                5 June 2020
                2021
                : 28
                : 2
                : 1198-1208
                Affiliations
                [1 ]GRID grid.11598.34, ISNI 0000 0000 8988 2476, Department of Gastroenterology and Hepatology, , Medical University of Graz, ; Graz, Austria
                [2 ]GRID grid.459837.4, Department of Abdominal Surgery and Oncology, , National Cancer Institute, ; Vilnius, Lithuania
                [3 ]GRID grid.6441.7, ISNI 0000 0001 2243 2806, Clinic of Gastroenterology, Nephrourology and Surgery, Institute of Clinical Medicine, Faculty of Medicine, , Vilnius University, ; Vilnius, Lithuania
                [4 ]GRID grid.459837.4, National Cancer Institute, ; Vilnius, Lithuania
                [5 ]Biovis Diagnostik, Limburg, Germany
                [6 ]GRID grid.11598.34, ISNI 0000 0000 8988 2476, Department of Transplantation Surgery, , Medical University of Graz, ; Graz, Austria
                Author information
                http://orcid.org/0000-0003-1848-2960
                Article
                8678
                10.1245/s10434-020-08678-1
                7801296
                32504369
                6ac53454-8776-41d6-9e4a-252a713916b6
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 12 February 2020
                Categories
                Translational Research and Biomarkers
                Custom metadata
                © Society of Surgical Oncology 2021

                Oncology & Radiotherapy
                Oncology & Radiotherapy

                Comments

                Comment on this article